Ilomedin

Iloprost trometamol, the active ingredient in Ilomedin, is a prostacyclin analog presented as a sterile intravenous solution for intravenous use. It is employed to manage pulmonary arterial hypertension, digital ischemia, and Raynaud's phenomenon in adult patients. GNH USA supplies Ilomedin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ilomedin is a prostacyclin analog used in vascular disorders that benefit from vasodilation and platelet inhibition.

Pulmonary arterial hypertension: improves exercise capacity and reduces pulmonary vascular resistance. Digital ischemia: restores blood flow to ischemic digits, relieving pain and promoting healing. Raynaud's phenomenon: alleviates vasospasm episodes and improves peripheral circulation.

Ilomedin may cause a range of adverse reactions, most of which are related to its vasodilatory properties.

Common Side Effects: - Headache: mild to moderate, often transient. - Flushing: warm sensation and reddening of skin. - Nausea or vomiting: gastrointestinal discomfort. - Jaw or dental pain: discomfort during infusion. - Hypotension: mild drop in blood pressure. - Cough or throat irritation: related to IV administration.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring intervention. - Pulmonary edema: fluid accumulation in lungs. - Significant bleeding: due to platelet inhibition. - Thrombocytopenia: reduced platelet count. - Anaphylactic reaction: rare hypersensitivity. - Chest pain or myocardial ischemia: rare cardiac events.

When prescribing Ilomedin, clinicians should consider several safety measures.

Monitor blood pressure: check regularly for hypotension during and after infusion. Assess bleeding risk: avoid in patients with active hemorrhage or uncontrolled coagulopathy. Use caution in renal impairment: adjust monitoring as renal clearance may be affected. Avoid in pregnancy unless benefits outweigh risks: limited human data available. Avoid in severe hepatic impairment: insufficient safety data. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedin can interact with other medications that affect vascular tone or coagulation.

Major Interactions (Avoid): - Concomitant potent vasodilators (e.g., nitroglycerin): may cause severe hypotension. - Anticoagulants (e.g., warfarin, heparin): increased risk of bleeding. - Endothelin receptor antagonists: additive vasodilatory effect.

Moderate Interactions (Monitor Closely): - Phosphodiesterase inhibitors (e.g., sildenafil): may enhance vasodilation. - CYP450 enzyme inhibitors: potential alteration of iloprost metabolism. - Other prostacyclin analogs: increased incidence of adverse events.